Apixaban (Eliquis) for prevention of thromboembolic events in patients with atril fibrillation

Abstract

Summary on new peroral anticoagulant drug apixaban, which was recently registered for prevention of thromboembolic events in atrial fibrilation.

Keywords

• Apixaban
• atrial fibrillation
• stroke prevention